Analysis of risk factors for sternal surgical site infection: Emphasizing the appropriate ventilation of the operating theaters

Infection Control and Hospital Epidemiology

Volumn 27, Issue 9, 2006, Pages 958-963

  Yavuz, Serap Simsek ^a,c   Bicer, Yesim ^a   Yapici, Nihan ^a   Kalaca, Sibel ^b   Aydin, Osman Ozcan ^a   Camur, Gercek ^a   Kocak, Funda ^a   Aykac, Zuhal ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; HEART SURGERY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OPERATING ROOM; OPERATION DURATION; RISK FACTOR; STERNOTOMY; STERNUM; SURGICAL INFECTION;

CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; DIABETES COMPLICATIONS; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; OPERATING ROOMS; POSTOPERATIVE CARE; RISK FACTORS; SURGICAL WOUND INFECTION; TURKEY; VENTILATION;

EID: 33748994588     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/506399     Document Type: Article

References (22)

1. Greenblatt J, Fischer RA. Complications of cardiac surgery: infections. In: Kotler MN, Alfieri A, eds. Cardiac and Noncardiac Complications of Open Heart Surgery: Prevention, Diagnosis and Treatment. New York: Futura; 1992:145-176.
2. Kollef MH, Sharpless L, Vlasnik J, Pasque C, Murphy D, Fraser V. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest 1997; 112:666-675.
3. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. In: Olmsted RN, ed. APIC Infection Control and Applied Epidemiology: Principles and Practice. St. Louis: Mosby; 1996: A1-A20.
4. Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance system basic SSI risk index. Clin Infect Dis 2001; 33:S69-S77.
5. Kluytman JAJW, Mouton JW, Maat APWM, Manders MAAJ, Michel MF, Wagenvoort JHT. Surveillance of postoperative infections in thoracic surgery. J Hosp Infect 1994; 27:139-147.
6. Rebello MH, Bernal JM, Llorca J, Rabasa JM, Revuelta JM. Nosocomial Infections in patients having cardiovascular operations: a multivariate analysis of risk factors. J Thorac Cardiovasc Surg 1996; 112:908-913.
7. NNIS National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 2002; 30:458-475.
8. Russo PL, Spelman DW. A new surgical-site infection risk index using risk factors identified by multivariate analysis for patients undergoing coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 2002; 23:372-376.
9. Kohli M, Yuan L, Escobar M, et al. A risk index for sternal surgical wound infection after cardiovascular surgery. Infect Control Hosp Epidemiol 2003; 24:17-25.
10. Vuorisalo S, Haukipuro K, Pokela R, Syrjala H. Risk features for surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol 1998; 19:229-33.
11. Bellchambers J, Haris JM, Cullinan P, Gaya H, Pepper JR. A prospective study of wound infection in coronary artery surgery. Eur J Cardiothorac Surg 1999; 15:45-50.
12. Rupp ME. Mediastinitis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier-Churchill Livingstone; 2005:170-178.
13. El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg 1996; 61:1030-1036.
14. Bundy JK, Gonzalez VR, Barnard BM, Hardy RJ, DuPont HL. Gender risk differences for surgical site infections among a primary coronary artery bypass graft surgery cohort. Am J Infect Control 2003; 31. Poster 151.
15. Kollef MH, Copeland M, Senkowski C, et al. Macromastia as a factor in sternal wound dehiscence following cardiac surgery: management combining chest wall reconstruction and reduction mammoplasty. J Card Surg 1992; 7:275-278.
16. Ridderstolpe L, Gill H, Granfeldt H, Ahlfeldt H, Rutberg H. Superficial and deep sternal wound complications: incidence, risk factors and mortality. Eur J Cardiothorac Surg 2001; 20:1168-1175.
17. Zacharias A, Habib RH. Factors predisposing to median sternotomy complications. Deep vs superficial infection. Chest 1996; 110:1173-1178.
18. Olsen M, Lock-Buckley P, Hopkins D, Polish LB, Sundt TM, Fraser VJ. The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg 2002; 124:136-145.
19. Trick WE, Scheckler WE, Tokars JI, et al. Modifiable risk factors associated with deep sternal surgical site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2000; 119:108-114.
20. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, the Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999; 20:250-278.
21. Clark RE, Amos WC, Higgins V, Bemberg KF, Weldon CS. Infection control in cardiac surgery. Surgery 1976; 79:89-96.
22. Ferrazzi P, Allen R, Crupi G, Reyes I, Parenzan L, Maisonnet M. Reduction of infection after cardiac surgery: a clinical trial. Ann Thorac Surg 1986; 42:321-325.